RAPT Therapeutics to Participate in Several Upcoming Investor Conferences in September
August 30 2023 - 4:05PM
RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage,
immunology-based therapeutics company focused on discovering,
developing and commercializing oral small molecule therapies for
patients with significant unmet needs in inflammatory diseases and
oncology, today announced that members of the RAPT management team
will participate in the following investor conferences in
September:
- Wells Fargo 2023 Healthcare Conference –
Fireside chat on Wednesday, September 6, 2023 at 8:00 a.m. ET
- H.C. Wainwright 25th
Annual Global Investment Conference – Presentation
on Monday, September 11, 2023 at 2:00 p.m. ET
- Stifel 2023 Immunology and Inflammation Virtual
Summit – Fireside chat on Tuesday, September 19, 2023 at
3:45 p.m. ET
- Cantor Global Healthcare Conference –
Presentation on Tuesday, September 26, 2023 at 10:35 a.m. ET
To access the available live webcasts or subsequent archived
recordings of the discussions and presentations, please visit the
RAPT Therapeutics website at
https://investors.rapt.com/events-and-presentations.
About RAPT Therapeutics, Inc.RAPT Therapeutics
is a clinical-stage, immunology-based therapeutics company focused
on discovering, developing and commercializing oral small molecule
therapies for patients with significant unmet needs in inflammatory
diseases and oncology. Utilizing its proprietary discovery and
development engine, the Company is developing highly selective
small molecules designed to modulate the critical immune drivers
underlying these diseases. RAPT has discovered and advanced two
unique drug candidates, RPT193 and FLX475, each targeting C-C motif
chemokine receptor 4 (CCR4), for the treatment of inflammation and
cancer, respectively. The Company is also pursuing a range of
targets that are in the discovery stage of development.
Investor Contact:Sylvia
Wheelerswheeler@wheelhouselsa.com
Media Contact:Aljanae
Reynoldsareynolds@wheelhouselsa.com
RAPT Therapeutics (NASDAQ:RAPT)
Historical Stock Chart
From Mar 2024 to Apr 2024
RAPT Therapeutics (NASDAQ:RAPT)
Historical Stock Chart
From Apr 2023 to Apr 2024